A radioimmunoassay for the binding protein for vitamin D and its metabolites (DBP) has been developed. Suitable rabbit anti-DBP antiserum was elicited after primary and one booster injection. Anti-DBP antisera, as well as antigroup-specific component antisera, produced a single, monospecific line of percipitation when reacted against purified DBP and human serum. DBP was iodinated with 125I and 125I-DBP was purified by gel filtration on Sephadex G-200. Binding of 125I-DBP by 20 nl of rabbit anti-DBP antisera was approximately 50% and was sharply competed for by 0.4-4.0 ng of DBP standard. Displacement of 125I-DBP by human serum dilutions or standard DBP gave identical curves, and only weak competition was observed with old and new world primate sera. Apoand holo-DBP possessed indistinguishable immunoreactivity. The assay detects DBP in 1-10 nl of human serum with reasonable accuracy and with reasonable intra-and interassay precision. The mean serum concentration (+/-SEM) for a group of 40 normal adults was 525 +/-24 mug/ml and no sex difference was observed. Higher levels were found in sera from pregnant women and women receiving oral contraceptives, and decreased concentrations were observed in premature cord and hypoproteinemic sera. No significant correlation between serum DBP levels and serum 25-hydroxycalciferol levels was found, and the DBP content of sera from vitamin D-deprived and vitamin D-treated subjects was indistinguishable from […] A B S T R A C T A radioimmunoassay for the binding protein for vitamin D and its metabolites (DBP) has been developed. Suitable rabbit anti-DBP antiserum was elicited after primary and one booster injection. Anti-DBP antisera, as well as antigroup-specific component antisera, produced a single, monospecific line ofprecipitation when reacted against purified DBP and human serum. DBP was iodinated with 125J and 125I-DBP was purified by gel filtration on Sephadex G-200. Binding of 125I-DBP by 20 nl of rabbit anti-DBP antisera was approximately 50% and was sharply competed for by 0.4-4.0 ng of DBP standard. Displacement of 125I-DBP by human serum dilutions or standard DBP gave identical curves, and only weak competition was observed with old and new world primate sera. Apo-and holo-DBP possessed indistinguishable immunoreactivity. The assay detects DBP in 1-10 nl of human serum with reasonable accuracy and with reasonable intra-and interassay precision.
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INTRODUCTION
Antiricketic sterols are transported in the human circulation by an inter-alpha globulin which has recently been characterized (1) (2) (3) (4) (5, 6) . We report the development of a radioimmunoassay for the human serum binding protein for vitamin D and its metabolites (DBP). The serum level of DBP has been determined in normal subjects and patients, and the relation between serum DBP and 25-hydroxycalciferol has been examined. Purification of '251-DBP. Immediately after the iodination procedure, 1 ml of the iodination solution was applied to a 1 x 45-cm column of Sephadex G-200 that had been equilibrated in the Tris-albumin buffer. The filtration was carried out by ascending flow (15 ml/hr) at 4°C, and 1-2-ml fractions were collected. 125I-DBP (mol wt -58,000) eluted after the void volume and before 125I (Fig. 1) . Estimates of specific activity achieved were usually 50 uCi/,ug, and >95% of the 125I-DBP purified on the G-200 column was bound by an excess of the rabbit anti-DBP antiserum.
METHODS
Immunoassay procedure. Pilot studies indicated the merit of a double-antibody precipitation technique, and the relatively low nonspecific precipitation of 125-DBP in the Trisalbumin buffer. Suitable binding curves were reproducibly achieved by permitting a 2-day incubation of first antibody, followed by an overnight incubation with goat-antirabbit gamma globulin.
Tris-albumin buffer, DBP reference standard diluted in Tris-albumin buffer, or human serum diluted in Tris-albumin buffer were added to 10 x 75-mm disposable glass tubes. 125I-DBP (approximately 15,000 cpm or 300-400 pg), diluted in the same buffer containing carrier rabbit (nonimmune) sera, was added, followed by 20 nl of rabbit anti-DBP antisera in 0.1 ml of the Tris-albumin buffer (final dilution 1:25,000). The tubes were kept at 0°C during the procedure, and the order of additions and final incubation volume (0.5 ml) were always the same. After mixing on a Vortex apparatus, the tubes were covered and placed at 40C for 48 h. Goat antirabbit gamma globulin antiserum (Gateway Immunosera Co., Cahokia, Ill.) (50 1.d) was added and the tubes were kept at 40C for an additional 16 h. After the second incubation, the tubes were centrifuged at 2,000 rpm for 20 min at 40C. Supemates were removed, and the precipitates were washed with 0.5 ml of the Trisalbumin buffer. After a second centrifugation and removal of supermates, the precipitates were assayed in a gamma spectrometer (Searle Analytic Inc., Des Plaines, Ill.) with a counting efficiency of 40%/ of 125I.
Each assay contained replicate tubes without antibody, replicate tubes with antibody and 125I-DBP, reference DBP dilutions in triplicate, and dilutions of reference pooled sera. Typically, the antibody control tubes revealed 40-50% of the 1251-DBP to be antibody-bound in the absence of unlabeled DBP. In each assay, tubes containing excess anti-DBP (0.1 ml of 1:100 dilution) and 125I-DBP revealed >95% of the 125I-DBP to be bound by the rabbit anti-DBP. Nonspecific 1251-DBP precipitation (in absence of anti-DBP) was 8% or less, and was subtracted from the counts per minute observed in the precipitates of tubes containing anti-DBP. Radioactivity precipitated in the presence of standard or serum was divided by that precipitated in the absence of unlabeled DBP to calculate B/Bo. 25-OHD assay. The serum content of 25-OHD (25-OHD3 and 25-OHD2 equally recognized) was determined by ether extraction, silicic acid chromatography, and competitive protein binding radioassay as previously described (8) .
Serum samples. Venous blood was obtained from healthy men and women and from patients with a variety of disorders (Table II) . Samples were also obtained from healthy women receiving chronic oral contraceptive therapy (estrogen and progestins), pregnant (last trimester) women, and from cord at the delivery of term and premature infants. Sera from patients previously identified to have osteomalacia Immunodiffusion studies. Agar (0.6% in 0.01 M Tris-HC1 containing 0.1 M NaCl, pH 7.5) slides were prepared. IgG fractions of rabbit anti-DBP and antigroup-specific component (Gc) antisera (Behring Diagnostics, American Hoechst Corp., Somerville, N. J.) were prepared by 33% (NH4)2 SO4 precipitation, dialysis, and chromatography on 1 x 17-cm columns of DEAE-cellulose equilibrated in the dialyzing buffer, 0.02 M potassium phosphate, pH 8.0. These IgG fractions were lyophilized, reconstituted, and allowed to diffuse against various sera and the purified DBP preparation.
RESULTS
Anti-DBP antiserum. The antiserum obtained after injections of DBP gave a single precipitin line when allowed to diffuse against DBP (Fig. 2A) . Similarly, when tested against normal human serum, the anti-DBP caused a single line of precipitation. The reactions between anti-DBP and DBP and anti-DBP and human serum described a single, monospecific immunoprecipitin line ( Fig. 2A) . Fig. 2B indicates that indistinguishable results were observed when anti-Gc antiserum was substituted for the anti-DBP. Identical results were obtained over a range (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) When normal human serum was diluted in the albumin buffer and assayed concurrently with standard DBP, the assay curve obtained with the serum dilutions was essentially identical to displacement observed with reference DBP (Fig. 3) .
Accuracy. Known amounts of standard DBP were added to replicate dilutions of normal human serum and analyzed in the immunoassay. As indicated in Table I , the mean recovery of added DBP was 102% in both instances.
Intra-Assay variation. Two sera were analyzed in 10 replicate tubes within the same assay, and the coefficients of variation were 3.2 and 5.7% (Table I) . Serum samples were routinely assayed in duplicate and at two separate dilutions (2 and 10 nl/tube). When duplicate assays differed from each other by more than 20%, the assay of the sample was repeated.
In each of eight separate assays over a 4-mo period, dilutions from the same serum pool were analyzed in duplicate at two different dilutions. As indicated in Table I , the mean +SD observed was 633 +58 Ag/ml. Fig.  4 , the displacement of 125I-DBP by human sera was most potent, with old and new world primate sera much less so. Dog and chicken sera were also noncompetitive in this system. When serum was fractionated by polyacrylamide gel electrophoresis or sucrose gradient ultracentrifugation, a homogeneous peak of DBP was observed by immunoassay of gel slice eluates and gradient fractions.
Serum DBP concentrations. The mean serum DBP concentration (±SEM) for normal adults was 525±24 ,g/ml (Table II) . No difference in DBP levels between men and women were observed. Similarly, serum DBP levels were not altered in vitamin Ddeprived nor vitamin D-treated subjects. Significantly lower values were observed in cord sera from prematurely delivered infants and patients (cirrhosis, nephrotic syndrome, and intestinal telangiectasia) with hypoproteinemia (serum albumin <2.8). Increased levels were observed in sera from pregnant females (1,254±89 ,ug/ml, mean±SEM) and females taking oral contraceptives (824±51 ug/ml, mean ±SEM). Subjects with X-linked vitamin D-resistant rickets, sarcoidosis, as well as those receiving chronic adrenocorticosteroid or anticonvulsant therapy, had normal serum DBP levels. The sera of normal children (aged 7-13 yr) and term cord sera contained levels of DBP that were indistinguishable from those of normal adults. A normal DBP concentration was also found in the serum from one patient with vitamin D-dependent rickets.
Serum DBP and serum 25-OHD. Although no differences in serum DBP content were observed among vitamin D-deprived, normal, and vitamin D-treated subjects, we analyzed sera from subjects before and after the oral or parenteral administration of vitamin D or 25-OHD3. At hours, days, and weeks after the doses, no significant changes in serum DBP concentrations were found. Fig. 5 displays the paired serum DBP and serum 25-OHD levels observed in 31 adult sera. No significant correlation was found in this group of sera. The mean DBP concentration is 572 ,g/ml (approximately 10 ,uM) and the mean 25-OHD concentration is 19.7 ng/ml (50 nM. The data clearly indicate the striking molar excess of binding protein to this ligand in normal sera.
DISCUSSION
An accurate and convenient radioimmunoassay for the binding protein for vitamin D and its metabolites in human serum (DBP) has been developed. The immunoassay has a reasonable degree of intra-assay and inter-assay precision. The assay is sensitive to nanogram and sub-nanogram amounts of DBP, thus requiring dilution of serum. This degree of sensitivity permits the reliable quantitation of DBP in as little as 2-10 nl of serum per assay tube. Serum DBP is apparently stable for immunoassay purposes, since aliquots from the same frozen serum pool were repetitively measured to be very similar over a 6-mo period.
The immunoassay is specific for human DBP, and (4) . Further, our present observations (Table II) indicate the concentration of DBP in human sera to be about 9 ,M. Assuming a mole per mole relationship between DBP and each of the vitamin D sterols (4) only 2-3% of the binding sites are occupied in normal man. Since no apparent relationship between serum DBP concentration and serum 25-OHD concentration was observed (Fig. 5 ) and since DBP levels were similar in vitamin D-deprived and vitamin D-treated subjects (Table II) , it seems probable that vitamin D availability and metabolism does not significantly affect the synthesis or catabolism of DBP. If this proves to be the case, the serum binding protein for vitamin D sterols differs from retinol-binding protein, since the hepatic egress of retinol-binding protein is made possible by the availability of its ligand (11) .
Our studies do not identify the organ(s) of genesis of DBP but indicate that DBP levels are increased in pregnant women and women taking oral contraceptives (Table II) . It seems likely, therefore, that DBP might originate in the liver and that its synthesis, as with certain other serum proteins during estrogen therapy (12) , is augmented by estrogen administration. The lower DBP levels in premature cord sera might also reflect hepatic immaturity, since term cord levels were found to be like those of adults. Since even the premature cord levels of DBP most likely represent an excess of carrier protein to ligand, the demonstrated close relationship of maternal serum and premature cord 25-OHD concentrations (13) is not surprising. The recent demonstration of the vitamin D and 25-OHD binding properties of Gc is of considerable interest (14) . Earlier estimates of serum Gc concentration were slightly higher than those presently observed and indicated the likelihood that Gc or DBP was of hepatic origin (15) . Available evidence suggests the identity of Gc and DBP and provides the basis for asking whether or not the recognized Gc variants (16) (Table II) identify it to be a major serum constituent since it represents approximately 6% of the serum alpha globulins.
